Symptomatic intravenous antipyretic therapy: Efficacy of metamizol, diclofenac, and propacetamol

Journal of Pain and Symptom Management

Volumn 24, Issue 6, 2002, Pages 608-615

  Obořilová, Andrea ^a   Mayer, Jiří ^a   Pospíšil, Zdeněk ^b   Kořístek, Zdeněk ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Diclofenac; Febrile neutropenia; Fever; Metamizol; Propacetamol

Indexed keywords

ANTIPYRETIC ANALGESIC AGENT; DICLOFENAC; DIPYRONE; PROPACETAMOL;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY TEMPERATURE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SCHOOL CHILD; SIDE EFFECT; SKIN IRRITATION; TREATMENT OUTCOME;

ACETAMINOPHEN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; DICLOFENAC; DIPYRONE; FEMALE; FEVER; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS;

EID: 0344951322     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(02)00520-1     Document Type: Article

References (42)

1. Schachter J. Fever in oncology. Isaac B., Kernbaum S., Burke M. Unexplained fever. 1991;381-385 CRC Press Inc, Boca Raton, FL.
2. Kernbaum S. Unexplained fever in the immunocompromised patient. Isaac B., Kernbaum S., Burke M. Unexplained fever. 1991;355-364 CRC Press Inc, Boca Raton, FL.
3. Sickles E.A., Green W.H., Wiernik P.H. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med. 135:1975;715-719.
4. Drwal-Klein L.A., Phelps J. Antipyretic therapy in the febrile child. Clin Pharm. 11:1992;1005-1021.
5. Fischler M.P., Reinhart W.H. Fieber. Freund oder Feind? Schweiz Med Wochenschr. 127:1997;864-870.
6. Kramer M.S., Naimark L.E., Roberts-Brauner R. Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet. 337:1991;591-594.
7. Leatherman J.W., Schmitz P.G. Fever, hyperdynamic shock and multiple-system organ failure (a pseudo-sepsis syndrome associated with chronic salicylate intoxication). Chest. 100:1991;1391-1396.
8. Styrt B., Sugarman B. Antipyresis and fever. Arch Intern Med. 150:1990;1589-1597.
9. Adam D., Stankov G. Treatment of fever in childhood. Eur J Pediatr. 153:1994;394-402.
10. Bock H.E. Fieberzustände - diagnostische und therapeutische Problematik. Med Welt. 40:1989;1109-1111.
11. Brück K. Fieber-biokybernetische Vorstellungen und neurophysiologische Grundlagen. Med Welt. 40:1989;1112-1119.
12. Burke M., Merdler C. Thermometry. Isaac B., Kernbaum S., Burke M. Unexplained fever. 1991;33-39 CRC Press Inc, Boca Raton, FL.
13. Coceani F., Lees J., Redford J., Bishai I. Interleukin-1 receptor antagonist. effectiveness against interleukin-1 fever Can J Physiol Pharmacol. 70:1992;1590-1596.
14. Eskerud J.R., Hofvedt B.O., Laerum E. Fever. knowledge, perception and attitudes. Results from a Norwegian Population Study Fam Pract. 8:1991;32-36.
15. Mackowiak A.P. Fever. blessing or curse? Unifying hypothesis Ann Intern Med. 120:1994;1037-1040.
16. Mackowiak P.A., Wasserman S.S., Levine M.M. A critical appraisal of 98.6°F, the upper limit of the normal body temperature and other legacies of Carl Reinhold August Wunderlich. JAMA. 268:1992;1578-1580.
17. Gewirtz A.M., Schick B. Platelet production and function. Colman W. Hemostasis and thrombosis. 1994;694-695 J.B.Lippincott Company, Philadelphia.
18. Payan D.G. Nonsteroidal analgetics. Katzung B.G. Basic and clinical pharmacology. 1994;511-535 Prentice Hall Inc, San Francisco.
19. Armelini P.A. Study comparing the antipyretic potency of diclofenac potassium and dipyrone magnesium in children. Invest Med Int. 11:1984;126-129.
20. Bettini R., Grossi E., Rapazzini P., Giardina G. Diclofenac sodium versus acetylsalicylic acid. a randomized study in febrile patients J Int Med Res. 14:1986;95-100.
21. Cedrato A.E., Passarelli I., Cimollini L., Maccarone H. Comparison of the antipyretic effect of a single dose of dipyrone, paracetamol and diclofenac resinate. A multicenter clinical trial. Medicina. 49:1989;635-636.
22. Graham N.M., Burrel C.J., Douglas R.M.et al. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding and clinical status in rhinovirus-infected volunteers. J Infect Dis. 162:1990;1277-1282.
23. McIntyre J., Hull D. Comparing efficacy and tolerability of ibuprofen and paracetamol in fever. Arch Dis Child. 74:1996;164-167.
24. Pesenti A., Riboni A., Basilico E., Grossi E. Antipyretic therapy in ICU patients. evaluation of low dose diclofenac sodium Intensive Care Med. 12:1986;370-373.
25. Small R.E. Diclofenac sodium. Clin Pharm. 8:1989;545-558.
26. Walson P.D., Galletta G., Braden N.J., Alexander L. Ibuprofen, acetaminophen and placebo treatment of febrile children. Clin Pharmacol Ther. 46:1989;9-17.
27. Doyle D., Hanks G.W.C., Macdonald N. Oxford textbook of palliative medicine. 1993;Oxford University Press, Oxford.
28. Woodruff R. Palliative medicine. 1996;Asperula Pty Ltd, Melbourne, Australia.;419.
29. Klein N.C., Cunha B.A. Treatment of fever. Infect Dis Clin North Am. 10:1996;211-216.
30. Kluger M.J. Fever revisited. Pediatrics. 90:1992;846-850.
31. Kluger M.J., Kozak W., Conn C.A.et al. The adaptive value of fever. Infect Dis Clin North Am. 10:1996;1-20.
32. Kozak W. Fever. a possible strategy for membrane homeostasis during infection Perspective Biol Med. 37:1993;14-34.
33. Vargas R., Maneatis T., Bynum L.et al. Evaluation of the antipyretic effect of ketorolac, acetaminophen and placebo in endotoxin-induced fever. J Clin Pharmacol. 34:1994;848-853.
34. Greisman S.E. Cardiovascular alterations during fever. Mackowiak P.A. Fever. basic mechanisms and management:1991;143-165 Raven Press, New York.
35. Hibberd P.L., Rubin R.H. Fever in immunocompromised host. Mackowiak P.A. Fever. basic mechanisms and management:1991;197-218 Raven Press, New York.
36. O'Donnell O., Axelrod P., Fisher C., Lorber B. Use and effectiveness of hypothermia blankets for febrile patients in the intensive care unit. Clin Inf Dis. 27:1997;1208-1213.
37. Reymond D., Birrer P., Lüthy A.R., Rimensberger P.C. Antipyretic effect of parenteral paracetamol (propacetamol) in pediatric oncologic patients. a randomized trial Pediatr Hematol Oncol. 14:1997;51-57.
38. Matzke G.R. Nonrenal toxicities of acetaminophen, aspirin and nonsteroidal anti-inflamatory agents. Am Journal of Kidney Dis. 28(Suppl 1):1996;63-70.
39. Shan F. Paracetamol. when, why and how much J Pediatr Child Health. 29:1993;84-85.
40. Mihajlovic G. Recall of metamizole from the market in countries with modern pharmacotherapy. Srp Arh Celok lek. 124:1996;44-46.
41. Roach J.A., Stacey B. Acetaminophen toxicity. Orthop Nurs. 16:1997;49-55.
42. Kaufman D.W., Kelly J.P., Levy M., Shapiro S. The drug etiology of agranulocytosis and aplastic anemia. 1991;170-203 Oxford University Press, New York.